# $dcth

Delcath Systems sees a surge in mentions and engagements, driven by discussions around its FDA-approved HEPZATO KIT and potential expansion into new indications. Investors are noting its undervalued status and long-term potential amidst some MedTech sector risks.

### About $dcth
Delcath Systems is a medical technology company specializing in cancer treatments, particularly for liver cancers.  

### Insights
- $dcth mentions hit [---] which is 106% higher than it's daily average.

### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$dcth/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$dcth/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [------]  
[--] Month: [------] -70%  
[--] Months: [---------] -33%  
[--] Year: [---------] +62%  
1-Year High: [-------] on 2025-03-05  
1-Year Low: [---] on 2025-04-22  

Engagements by network (24h):
Reddit: [--]
YouTube: [--]
X: [-----]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$dcth/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$dcth/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [--]  
1-Year High: [---] on 2025-11-22  
1-Year Low: [--] on 2025-09-14  

Mentions by network (24h):
Reddit: [--]
YouTube: [--]
X: [---]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$dcth/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$dcth/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning $dcth in the last [--] hours which is up 124% from [--] in the previous [--] hours
Daily Average: [--]  
1-Year High: [---] on 2025-06-29  
1-Year Low: [--] on 2025-04-12  

The most influential creators that mention $dcth in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | [--]    | [-----]     | [--]     | [---]         |
| [@jud_guy](/creator/twitter/jud_guy)                 | [--]    | [---]       | [--]     | [---]         |
| [@em013L](/creator/twitter/em013L)                   | [--]    | [------]    | [--]     | [---]         |
| [@Yam_Trades](/creator/twitter/Yam_Trades)           | [--]    | [-----]     | [--]     | [---]         |
| [@Signal_Trader08](/creator/twitter/Signal_Trader08) | [--]    | [--]        | [--]     | [---]         |
| [@Signal_Trader02](/creator/twitter/Signal_Trader02) | [--]    | [--]        | [--]     | [--]          |
| [@uboat159](/creator/twitter/uboat159)               | [--]    | [-----]     | [--]     | [--]          |
| [@ryshab](/creator/twitter/ryshab)                   | [--]    | [-----]     | [--]     | [--]          |
| [@DarcyHople82406](/creator/twitter/DarcyHople82406) | [--]    | [--]        | [--]     | [--]          |
| [@Kleem48044](/creator/twitter/Kleem48044)           | [--]   | [--]         | [--]     | [--]          |

[View More](/list/creators/$dcth/100)
  
  
### Sentiment: 68%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$dcth/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$dcth/time-series/sentiment.tsv)  
Current Value: 68%  
Daily Average: 84%  
[--] Month: 52% +4%  
[--] Months: 52% -48%  
[--] Year: 52% -48%  
1-Year High: 100% on 2025-02-14  
1-Year Low: 9% on 2025-12-18  

Most Supportive Themes:
- FDA-Approved Product and Revenue Story: (25%) Delcath has an FDA-approved product, HEPZATO KIT, for liver-dominant uveal melanoma, positioning it as a revenue-generating company rather than a preclinical one.
- Expansion into New Indications: (20%) Management is targeting additional indications for their platform, such as colorectal liver metastases, which could lead to a high-margin franchise.
- Undervalued with Upcoming Catalysts: (20%) The company is considered undervalued with anticipated catalysts, attracting investors looking for potential growth opportunities.
- Long-term Hold Potential: (15%) The stock is viewed as a long-term hold due to its unique position in the MedTech space, offering a contrast to the higher risks associated with biotech.
- Informative Podcast Discussion: (10%) A podcast discussed the Chopin trial, providing informative insights into the company's developments.
  
Most Critical Themes:
- MedTech Risks: (50%) While distinct from biotech risks, the company operates within the MedTech sector, which inherently carries its own set of risks.
- Management Blackout Period: (50%) Potential weakness in the stock may be linked to management entering a blackout period, which could pause buyback activities.
  

### Top $dcth Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"@Investinc_Intel Current No Brainers in this Stock Market: [--] / $DCTH Oncology Medical Device Worry: Complexity of the Sector [--] / $PLTR AI Software Worry: Still Expensive Valuation [--] / $PGY AI ABS Fintech Worry: State of Consumer Credit [--] / $HOOD Broker Worry: Crypto Markets"  
[X Link](https://x.com/thephiloinvest/status/2021364702345851164) [@thephiloinvest](/creator/x/thephiloinvest) 2026-02-10T23:24Z [---] followers, [---] engagements


"Delcaths largest institutional Investor bought more shares in the end of December The Canadian Biotech fund Rosalind Advisors Inc. increased its $DCTH to 19.76% (previously 11.28%) of the portfolio 13D Filing Increasing its ownership to 19.03% https://investors.delcath.com/node/18876/html https://investors.delcath.com/node/18876/html"  
[X Link](https://x.com/thephiloinvest/status/2021320361858502720) [@thephiloinvest](/creator/x/thephiloinvest) 2026-02-10T20:28Z [---] followers, [---] engagements


"@growthrapidly $AMZN and $GMGI by far - down the line $ABBV $IRMD $IREN $DLO $CIFR $SOFI $DCTH $ONDS $ZETA $GRAB $NU like to get some $MELI & $META again. Should not have sold"  
[X Link](https://x.com/uboat159/status/2021282270817157561) [@uboat159](/creator/x/uboat159) 2026-02-10T17:57Z [----] followers, [---] engagements


"$DAG $DCTH ⚠👀 Guys Don't miss the next move in a few hours. 💸➡ http://discord.com/invite/GZ3Xc87eub http://discord.com/invite/GZ3Xc87eub"  
[X Link](https://x.com/Signal_Trader08/status/2021207615414681869) [@Signal_Trader08](/creator/x/Signal_Trader08) 2026-02-10T13:00Z [--] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing